PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Molecular Microbiology and Immunology.\', \'Pathology and Laboratory Medicine.\', \'Hematology-Oncology Division, Department of Medicine.\', \'The Joint Program in Cancer Biology.\', \'Cancer Center at Brown University, and.\', \'Department of Biostatistics, Lifespan Health System, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.\', \'Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.\', \'Department of Immunology, Kurume University, School of Medicine, Kurume, Fukuoka, Japan.\', \'Department of Medicine, Brown University, Providence, Rhode Island, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1172/jci.insight.148749e148749
?:doi
?:hasPublicationType
?:journal
  • JCI insight
is ?:pmid of
?:pmid
?:pmid
  • 34747367
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all